Literature DB >> 33650492

Identifying patients with epilepsy at high risk of cardiac death: signs, risk factors and initial management of high risk of cardiac death.

Rainer Surges1, Sharon Shmuely2, Christoph Dietze3, Philippe Ryvlin4, Roland D Thijs5.   

Abstract

People with epilepsy have a three-fold increased risk of dying prematurely, and a significant proportion is due to sudden cardiac death or acute myocardial infarctions. The causes of increased cardiovascular morbidity and mortality in epilepsy are manifold and include acute or remote effects of epileptic seizures, the longstanding epilepsy itself or antiseizure treatments. Seizure-related cardiac arrhythmias are common and comprise bradyarrhythmia and asystole, atrial fibrillation and ventricular tachycardia. The most frequent clinically relevant seizure-related arrhythmia is ictal asystole that may require implantation of a cardiac pacemaker, whereas seizure-related ventricular tachycardias are only rarely reported. Takotsubo cardiomyopathy and myocardial infarction are rare complications and predominantly described in association with tonic-clonic seizures. Epilepsy-related cardiac complications include a disturbed cardiac autonomic nervous system and acquired dysfunction of the heart (recently defined as 'epileptic heart'), probably contributing to the abnormalities of cardiac repolarisation and elevated risk of sudden cardiac death in people with epilepsy. If successful, the use of antiseizure medication prevents seizure-related cardiac arrhythmias and remote cardiac complications. However, enzyme-inducing antiseizure medications have a negative impact on cardiovascular risk factors, which may further be aggravated by weight gain linked to specific antiseizure drugs. Given the severe consequences of cardiac risks, the aim of this educational review is to explain the many facets of cardiac complications and their underlying causes, and to enable the reader to recognize and manage these risks with the goal to mitigate the cardiac risks in people with epilepsy. Features of syncope are explained in detail, as syncope of all origins can be mistaken as epileptic seizures in people with or without epilepsy, and ictal syncope (i.e. seizure-induced syncope) can easily be ignored.

Entities:  

Keywords:  antiepileptic drugs; antiseizure medication; cardiac arrhythmias; coronary artery disease; electrocardiogram; premature mortality; sudden cardiac death; syncope

Year:  2021        PMID: 33650492     DOI: 10.1684/epd.2021.1254

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  4 in total

Review 1.  Autonomic manifestations of epilepsy: emerging pathways to sudden death?

Authors:  Roland D Thijs; Philippe Ryvlin; Rainer Surges
Journal:  Nat Rev Neurol       Date:  2021-10-29       Impact factor: 42.937

2.  Impact of Cardiac Injury on the Clinical Outcome of Children with Convulsive Status Epilepticus.

Authors:  Ahmed Ibrahim; Ahmed Megahed; Ahmed Salem; Osama Zekry
Journal:  Children (Basel)       Date:  2022-01-18

3.  Stroke and Ischemic Heart Disease With Enzyme-inducing Antiseizure Medications: Time to Change Prescribing Habits.

Authors:  David G Vossler
Journal:  Epilepsy Curr       Date:  2022-01-12       Impact factor: 7.500

Review 4.  The brain-heart interaction in epilepsy: implications for diagnosis, therapy, and SUDEP prevention.

Authors:  Giorgio Costagliola; Alessandro Orsini; Monica Coll; Ramon Brugada; Pasquale Parisi; Pasquale Striano
Journal:  Ann Clin Transl Neurol       Date:  2021-05-28       Impact factor: 4.511

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.